← Browse by Condition
Medical Condition

targeted therapy

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
NCT06764680 Phase 2
Recruiting

Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer

Enrollment
57 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT06356584 Phase 2
Recruiting

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Enrollment
62 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
View Trial →
NCT06307249 Phase 1
Recruiting

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Enrollment
50 pts
Location
Lebanon
Sponsor
Lebanese University
View Trial →